n-acetylsphingosine has been researched along with mk 2206 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chen, X; Ding, J; Feng, M; Gao, F; Hu, S; Liu, H; Lu, J; Luo, C; Shi, Y; Wang, J; Xie, Z; Xu, H | 1 |
1 other study(ies) available for n-acetylsphingosine and mk 2206
Article | Year |
---|---|
Discovery of novel ceramide analogs with favorable pharmacokinetic properties and combination with AKT inhibitor against colon cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Ceramides; Drug Design; Drug Synergism; Female; G1 Phase Cell Cycle Checkpoints; Heterocyclic Compounds, 3-Ring; Humans; Mice, Inbred BALB C; Naphthalenes; Neoplasms; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species | 2021 |